Cardinal Health, Inc. (CAH)
Cardinal Health distributes pharmaceuticals and medical products to healthcare customers. Its fiscal 2026 revenue rose 14 percent to $254.2 billion, driven by branded and specialty pharmaceutical sales.
| Ticker | CAH |
|---|
| Company | Cardinal Health, Inc. |
|---|
| Exchange | NYSE |
|---|
| Headquarters | DUBLIN, OH |
|---|
Income statement — period ending 2026-06-30
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent | $1,704,000,000 |
|---|
| Cost of Goods and Services Sold | $244,474,000,000 |
|---|
| Earnings Per Share, Basic | 7 USD/shares |
|---|
| Earnings Per Share, Diluted | 7 USD/shares |
|---|
| Goodwill, Impairment Loss | $184,000,000 |
|---|
| Gross Profit | $9,774,000,000 |
|---|
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $2,174,000,000 |
|---|
| Income Tax Expense (Benefit) | $469,000,000 |
|---|
| Interest Expense | $348,000,000 |
|---|
| Net Income (Loss) Attributable to Parent | $1,714,000,000 |
|---|
| Net Income (Loss) Attributable to Noncontrolling Interest | -$9,000,000 |
|---|
| Operating Income (Loss) | $2,613,000,000 |
|---|
| Other Nonoperating Income (Expense) | $31,000,000 |
|---|
| Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | $1,705,000,000 |
|---|
| Restructuring Charges | $106,000,000 |
|---|
| Revenues | $254,248,000,000 |
|---|
| Selling, General and Administrative Expense | $6,132,000,000 |
|---|
| Share-based Payment Arrangement, Noncash Expense | $367,000,000 |
|---|
| Weighted Average Number of Shares Outstanding, Diluted | 237,000,000 shares |
|---|
| Weighted Average Number of Shares Outstanding, Basic | 236,000,000 shares |
|---|
Sourced from SEC EDGAR/XBRL filings via StockSpectro.
View full interactive research on StockSpectro